H Vaverková

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh et al. · The Lancet · 2022 · 189 citations · Full text

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +7

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study

Michel Farnier, Maurizio Averna, Luc Missault et al. · International Journal of Clinical Practice · 2009 · 68 citations · Full text

Correlation of Uric Acid Levels and Parameters of Metabolic Syndrome

Ľubica Cibičková, Kateřina Langová, H Vaverková et al. · Physiological Research · 2017 · 61 citations · Full text

Inverse Association of Lipoprotein (a) With Markers of Insulin Resistance in Dyslipidemic Subjects

H Vaverková, David Karásek, Milan Halenka et al. · Physiological Research · 2017 · 45 citations · Full text

Apolipoprotein B100 Molecule, Hyperlipidemia, Insulin Signaling +16